Efficacy of the Intralesional Infusion of Local Anesthetic and Steroids After Major Abdominal Surgery: a Randomized Double Blind Phase III Trial

Trial Profile

Efficacy of the Intralesional Infusion of Local Anesthetic and Steroids After Major Abdominal Surgery: a Randomized Double Blind Phase III Trial

Completed
Phase of Trial: Phase III

Latest Information Update: 07 Mar 2017

At a glance

  • Drugs Methylprednisolone (Primary) ; Ropivacaine (Primary)
  • Indications Postoperative inflammation; Postoperative pain
  • Focus Pharmacogenomic; Therapeutic Use
  • Most Recent Events

    • 01 Mar 2017 Status changed from recruiting to completed.
    • 09 Feb 2015 Duration for primary end point that is total morphine consumption is changed from 48 hours to 7 days and so accordingly changed the inclusion criteria related to it, according to ClinicalTrials.gov record.
    • 09 Feb 2015 Planned End Date changed from 1 Jul 2014 to 1 Apr 2016 according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top